RB1 and cancer: The minimal set of changes necessary to obtain tumorigenic drug-resistant cells was found to be expression of telomerase and inactivation of p53 and pRb [63], thus as the pathways inactivated or activated in malignant neoplasms can also confer the ability to acquire drug resistance as was observed also in our populations of cells.